Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
- Citation:
- J Clin Oncol vol 32 (10) 1066-1073
- Year:
- 2014
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 3
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821 , P30 CA015083, P30 CA086862, P50 CA097274, P50 CA97274
- Corr. Author:
- Authors:
- Matthew J. Maurer Hervé Ghesquières Jean-Philippe Jais Thomas E. Witzig Corinne Haioun Carrie A. Thompson Richard Delarue Ivana N. Micallef Frédéric Peyrade William R. Macon Thierry Jo Molina Nicolas Ketterer Sergei I. Syrbu Olivier Fitoussi Paul J. Kurtin Cristine Allmer Emmanuelle Nicolas-Virelizier Susan L. Slager Thomas M. Habermann Brian K. Link Gilles Salles Hervé Tilly James R. Cerhan
- Networks:
- Study
- NCCTG-N0489
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Bios3, Bios4, Hema10, ORIGINAL REPORTS, Hematologic Malignancy